References

Heartburn Symptoms & Causes

  1. http://www.aboutgerd.org/site/symptoms/sleep-and-gerd
  2. Winkle, global segmentation research, 2010
  3. Basu, K. K. (2012), Concise guide to management of reflux disease in primary care. Prescriber, 23: 19–28. doi: 10.1002/psb.944
  4. Dyspepsia, Heartburn and Ulcers. (2007). Retrieved from: http://www.topalbertadoctors.org/download/355/dyspepsia_brochure.pdf

Indigestion Symptoms & Causes

  1. http://www.aboutgerd.org/site/symptoms/sleep-and-gerd
  2. Winkle, global segmentation research, 2010
  3. Murrey M (2013), A Rational Approach to Indigestion, Vitamin Retailer Magazine, VR 2013, VR 2013 04, VR Columns, VR Natural Medicine

Pregnancy

  1. Vicki Strugala, Julian Bassin, Valerie S. Swales, Stephen W. Lindow, Peter W. Dettmar, and Edward C. M. Thomas, “Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy,” ISRN Obstetrics and Gynecology, vol. 2012, Article ID 481870, 6 pages, 2012. doi:10.5402/2012/481870

Tips and Advice

  1. Basu, K. K. (2012), Concise guide to management of reflux disease in primary care. Prescriber, 23: 19–28. doi: 10.1002/psb.944
  2. Indigestion. (2013, October). Retrieved from: http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/indigestion/Pages/facts.aspx

FAQs

  1. Vicki Strugala, Julian Bassin, Valerie S. Swales, Stephen W. Lindow, Peter W. Dettmar, and Edward C. M. Thomas, “Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy,” ISRN Obstetrics and Gynecology, vol. 2012, Article ID 481870, 6 pages, 2012. doi:10.5402/2012/481870
  2. Winkle, global segmentation research, 2010

News & Information

  1. V. Strugala et al; The Journal of International Medical Research; 2010; 38: 449-457.
  2. Chevrel B. J-Int Med Res 1980; 8(4): 300-2”.
  3. Jafri N, Jafri W, Yakoob J, Islam M, Manzoor S, Jalil A, et al. Perception of gastroesophageal reflux disease in urban population in Pakistan. J Coll Physicians Surg Pak. 2005 Sep; 15(9):532-4.
  4. Journal of Pakistan Medical Association

 

Healthcare Professionals

Clinical Studies

  1. El-Serag H, cups A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in Primary Care and Community Studies. Aliment Pharmacol Ther. 2010; 32: 720-737
  2. Kahrilas PJ, et al. The acid pocket: A target for treatment in reflux disease? Am J Gastroenterol. 2013 Jul; 108 (7): 1058-64
  3. J Fletcher, et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 2001; 121 (4): 775-783
  4. Rohof W, et al. An alginate-antacid formulation localizes to the pocket acid to reduce acid reflux in patients with gastroesophageal reflux disease. Clinical Gastroenterology Hepatology. 2013; 11 (12): 1585-91
  5. V. Strugala et al; The Journal of International Medical Research; 2010; 38: 449-457.
  6. Chevrel B. J-Int Med Res 1980; 8(4): 300-2”.
  7. Manabe, N., Haruma, K., Ito, M., Takahashi, N., Takasugi, H., Wada, Y., Nakata, H., Katoh, T., Miyamoto, M. and Tanaka, S. (2012), Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial. Diseases of the Esophagus, 25: 373–380. doi: 10.1111/j.1442-2050.2011.01276.x

Symptomatic GERD

  1. S.K Niaz et al, Guidelines on Gastroesophageal reflux disease, Journal of Pakistan Medical Association, May 2015 issue, 532-541.
  2. Kahrilas PJ, et al. Am J Gastroenterol. 2013;108(7):1058−1064.
  3. Kahrilas PJ, et al. Am J Gastroenterol. 2013;108(7):1058−1064.
  4. Pandolfino JE, et al. Am J Gastroenterol. 2007;102(12):2633−2641.
  5. Clarke AT, et al. Gut. 2008;57(3):292−297.
  6. Beaumont H, et al. Gut. 2010;59(4):441−451.
  7. M. A. Kwiatek, et al. Aliment Pharmacol Ther 2011; 34: 59-66.
  8. Mandel KG,et al. Aliment Pharmacol Ther .2000;14:669-690.
  9. Hampson FC, et al. Drug Dev Ind Pharm. 2010;36(5):614−623.
  10. M. A. Kwiatek, et al.Aliment Pharmacol Ther. 2011;34(1):59−66.
  11. El Serag H et al. Aliment Pharmacol Ther 2010;32:720-37.
  12. Manabe N, et al. Dis Esophagus. 2012;25(5):373−380.
  13. Dettmar PW et al.Indian J Med Res 2006;123(4):517-524.
  14. Castell DO et al. Aliment Pharmacol Ther 2004;20 Suppl 9:14–25.
  15. Tobey NA et al. Am J Gastroenterol 2001;96(11):3062–70.
  16. Strugala V et al. J Pharm Pharmacol 2009;61(8):1021-1028.
  17. V. Strugala et al; The Journal of International Medical Research; 2010; 38: 449-457.
  18. Chevrel B. J-Int Med Res 1980; 8(4): 300-2”.

Pregnancy

  1. J. E. Richter, “Review article: the management of heartburn in pregnancy,” Alimentary Pharmacology and Therapeutics, vol.22, no. 9, pp. 749–757, 2005.
  2. Marrero JM, Goggin PM, de Caestecker JS, Pearce JM, Maxwell JD. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 1992;99: 731-4).
  3. Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy; Vicki Strugala et al.;International Scholarly Research Network, ISRN Obstetrics and Gynecology Volume 2012.
  4. V. Strugala et al; The Journal of International Medical Research; 2010; 38: 449-457.
  5. Chevrel B. J-Int Med Res 1980; 8(4): 300-2.

Ramadan

  1. Ipsos Marketing. Market Research Understanding of Heartburn & Indigestion - KSA 2012.
  2. Castell D.O, et al. Aliment Pharmacol Ther 2004;20 (Suppl.) 9):14-25.
  3. Fass R. Curr Gastroenterol Rep 2009;11(3):202-8.
  4. V Strugala, et al. The Journal of International Medical Research 2010;38:449-457.
  5. Mandel K. G, et al. Aliment Pharmacol Ther 2000; 14: 669-690
  6. Dettmar PW. Indian J Med Res 123, April 2006, Page 493-496